Stuttgart
15.07.26 | 08:18
0,069 Euro
-16,69 % -0,014
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,069 | 0,085 | 08:33 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.07. | SpineGuard Announces its H1 2026 Revenue | 365 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 26.05. | SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology | 557 | Business Wire | All patents now granted in the United States to enhance the safety of robots, navigation systems, and powered orthopedic or dental drills
Regulatory News:
SpineGuard (FR0011464452 ALSGD),... ► Artikel lesen | |
| 28.04. | SpineGuard: Official Launch of Three New PediGuard Models During the Annual Scoliosis Meeting in China | 503 | Business Wire | Presentation of PediGuard in plenary session
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing... ► Artikel lesen | |
| 13.04. | SpineGuard and Omnia Medical Complete US Asset Transfer and Enter Exclusive Distribution Agreement for PediGuard | 372 | Business Wire | Integration of PediGuard systems into Omnia Medical's portfolio across a broad range of spine indications, including minimally invasive and outpatient treatments Transaction supports SpineGuard's... ► Artikel lesen | |
| 08.04. | SpineGuard Announces Full-Year 2025 Financial Results, First Quarter 2026 Sales, and the Set-Up of a Bond Financing | 420 | Business Wire | Operating income improved by 46% Cash runaway extended to 2Q27
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 25.03. | SpineGuard Announces the Full Settlement of the Norgine and Harbert European Growth Bond Issues | 491 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD, PEA-PME eligible), an innovative company deploying its digital surgical guidance (DSG) technology-which measures tissue electrical conductivity... ► Artikel lesen | |
| 19.01. | SpineGuard Reports Its Full-year 2025 Revenue | 453 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its digital surgical guidance (DSG) technology, which measures the electrical conductivity of tissues in real... ► Artikel lesen | |
| 05.01. | SpineGuard Announces its 2026 Financial Calendar | 492 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| SPINEGUARD Aktie jetzt für 0€ handeln | |||||
| 17.12.25 | PhD Thesis Presentation of Positive Results Obtained by SpineGuard's New Ultrasound Technology | 453 | Business Wire | Feasibility of entry point and trajectory determination in vertebral drilling
Ideal complement of DSG real-time X Ray-free guidance technology
Collaboration with the LIB and ISIR... ► Artikel lesen | |
| 16.12.25 | SpineGuard: Completion of Capital Increase With Priority Period Maintained for a Gross Amount of €1.2 Million | 383 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its digital surgical guidance (DSG) technology based on local measurement of tissue electrical... ► Artikel lesen | |
| 09.12.25 | SpineGuard announces the launch of a capital increase with cancellation of preferential subscription rights and implementation of a priority period for shareholders for an initial gross amount of €1.6 million secured by commitments amounting to... | 610 | Business Wire | Subscription price: €0.1120 per share, representing a discount of 25.93% on the closing price of the share on December 8th, 2025 Priority period open from December 9th, 2025, to December... ► Artikel lesen | |
| 04.12.25 | SpineGuard Obtains the Clearance of Three New PediGuard Models in China | 436 | Business Wire | Extension to add the Curved and XS PediGuard models
Designation change
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 24.11.25 | SpineGuard Obtains a U.S. Patent on Its Universal Adapter for Orthopaedic Power Drills and Robots | 379 | Business Wire | Bone breach detection, automatic stop and additional functionalities
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance)... ► Artikel lesen | |
| 09.10.25 | SpineGuard Reports Its Q3 2025 Revenue | 509 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen | |
| 22.09.25 | SpineGuard Obtains European Patent on Automatic Bone Breach Detection by DSG, Applicable to Orthopedic Power Drills and Robots | 453 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline... ► Artikel lesen | |
| 10.09.25 | SpineGuard Reports 2025 Half-Year Results and Announces the Implementation of a Bond Financing | 647 | Business Wire | 54% improvement in operating result Implementation of a bond financing for up to €1,000,000
Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its... ► Artikel lesen | |
| 16.07.25 | SpineGuard Obtains US Patent on DSG-Enabled Active Safety Stop for Hand-Held Bone Drilling Power Tools in Free-Hand, Navigated or Robotically-Assisted Surgery | 606 | Business Wire | Regulatory News:
SpineGuard (FR0011464452 ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 41,020 | 0,00 % | DAX-Rekordjagd beendet - DHL Group, Fresenius, Rheinmetall, SAP und Talanx im Check | Die Rekordjagd im DAX ist zur Wochenmitte erst einmal beendet. Gewinnmitnahmen nach dem jüngsten Hochlauf, erneute Schwäche bei KI- und Halbleiterwerten sowie schwache Vorgaben aus Asien bremsen die... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,290 | 0,00 % | Siemens Healthineers: Berenberg wird vorsichtiger | Die Analysten der Privatbank Berenberg haben ihr Kursziel für Siemens Healthineers von 54 auf 39 € gesenkt und die Einstufung von "Buy" auf "Hold" reduziert. Die Begründung: Bei den Faktoren, die dem... ► Artikel lesen | |
| THERMO FISHER | 466,10 | -0,41 % | Persistence Market Research Pvt. Ltd.: Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG | LONDON, July 8, 2026 /PRNewswire/ -- Persistence Market Research, a leading management consulting firm, has released this update on the cell culture media market. These specialized nutrient... ► Artikel lesen | |
| TELADOC HEALTH | 8,078 | -0,42 % | Teladoc (TDOC) Rises Higher Than Market: Key Facts | ||
| EUROFINS SCIENTIFIC | 68,48 | +0,29 % | Eurofins Scientific SE: Weekly Report on Share Repurchases From 06th July to 10th July 2026 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Weekly report on share repurchases from 06th July to 10th July 2026 Name of the Issuer... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| DAVITA | 202,70 | -0,30 % | Ausnahmen Im KI-Rausch: 15 S&P-Aktien haben sich seit Jahresanfang verdoppelt - zwei davon ohne KI-Hype | © Foto: KI-generiert mit DALL-E15 Aktien aus dem S&P 500 haben sich 2026 bereits verdoppelt. 13 stammen aus dem KI-Umfeld. Nur Moderna und DaVita tanzen aus der Reihe. Können sie noch überraschen? Der... ► Artikel lesen | |
| SPINEWAY | 0,126 | 0,00 % | Spineway: First-quarter 2026 revenue | Ecully, April 30, 2026 - 6:00 p.m. First-quarter 2026 revenue High order volumeSlower-than-expected normalization of supply chains2026: growth trajectory confirmed In thousands of euros20262025Change... ► Artikel lesen | |
| DENTSPLY SIRONA | 11,195 | +0,63 % | DENTSPLY SIRONA Inc.: Dentsply Sirona Appoints John Fortson as Chief Financial Officer | CHARLOTTE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products... ► Artikel lesen | |
| SMITH & NEPHEW | 13,900 | +5,30 % | Smith & Nephew Plc: New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions | Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the publication of new consensus-based guidance - developed independently by expert clinicians for the use of... ► Artikel lesen | |
| SONIC HEALTHCARE | 12,960 | -0,26 % | Dividendenbekanntmachungen (04.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASPIAL LIFESTYLE LIMITED SG2E90982678 0,008 SGD 0,0053 EUR AUTOLIV INC US0528001094 0,87 USD 0,7491 EUR AVERY DENNISON CORP US0536111091 0... ► Artikel lesen | |
| DIASORIN | 69,44 | 0,00 % | DiaSorin speculated to have rebuffed takeover offer from US suitor - report | ||
| FULGENT GENETICS | 17,800 | 0,00 % | Fulgent reports interim data for cancer drug FID-007 trial | ||
| IMPLANTICA | 5,830 | +0,52 % | Implantica AG: Bulletin from the Annual General Meeting of Implantica AG | Today, June 10, 2026, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting resolved to adopt all of the board of directors' resolution... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 2,510 | -6,48 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor | SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering... ► Artikel lesen |
Das Unternehmen SPINEGUARD SA kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,014 (-16,69 %) liegt der Kurs bei 0,069 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SPINEGUARD SA finden Sie auf Wallstreet Online.